| Symbol | Company | Owner | Relationship | Date | Transaction | Cost | # Shares | Value ($) | Total Shares | Filing | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| BBIO | BridgeBio Pharma, Inc. | Valantine Hannah | Director | Feb 15, 2024 | Option Exercise | $23.10 | 5,830 | 134,673 | 4,679 | Feb 20, 2024, 04:03 PM | |
| BBIO | BridgeBio Pharma, Inc. | Valantine Hannah | Director | Dec 28, 2021 | Buy | $12.96 | 3,433 | 44,476 | 3,433 | Feb 13, 2024, 04:00 PM | |
| BBIO | BridgeBio Pharma, Inc. | Valantine Hannah | Director | Jan 16, 2024 | Option Exercise | $23.21 | 5,830 | 135,314 | 4,679 | Jan 18, 2024, 04:10 PM | |
| BBIO | BridgeBio Pharma, Inc. | Valantine Hannah | Director | Dec 15, 2023 | Option Exercise | $22.28 | 5,830 | 129,922 | 4,679 | Dec 19, 2023, 04:00 PM | |
| BBIO | BridgeBio Pharma, Inc. | Valantine Hannah | Director | Nov 15, 2023 | Option Exercise | $19.22 | 5,830 | 112,082 | 4,679 | Nov 17, 2023, 04:09 PM | |
| BBIO | BridgeBio Pharma, Inc. | Valantine Hannah | Director | Dec 29, 2021 | Buy | $14.23 | 1,764 | 25,102 | 1,764 | Jan 03, 2022, 07:53 PM |
Menu